Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN

ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE

Standard Dose
325MG;32MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN is listed in Drugs@FDA under application 083689 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE Form and strength TABLET;ORAL - 325MG;32MG Sponsor MYLAN Submission history Latest submission status date: 1974-10-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN is listed in Drugs@FDA under application 083689 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE Form and strength TABLET;ORAL - 325MG;32MG Sponsor MYLAN Submission history Latest submission status date: 1974-10-25 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE) | Drug Monograph | MedicHelpline